RNF185 and prostate carcinoma: Collagen type III alpha 1 chain (COL3A1) has been identified as the main mediator of RNF185’s ability to promote the migration phenotype in prostate cancer cells as COL3A1 inhibition was capable of attenuating the migration and metastasis of the cancer cells [45].